| [1] |
TAN Libo, LIU Nanyang, LI Hao.
Evidence Mapping Analysis of Clinical Studies on Treatment of Alzheimer's Disease with Chinese Patent Medicines
[J]. Chinese General Practice, 2026, 29(32): 4805-4814.
|
| [2] |
WEI Baian, YU Yan, QIU Xingying, GUO Xinfeng, YANG Lihong.
The Delphi Critical Appraisal Tool: Interpretation and Practical Applications
[J]. Chinese General Practice, 2026, 29(32): 4700-4709.
|
| [3] |
CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong.
Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review
[J]. Chinese General Practice, 2026, 29(29): 4200-4210.
|
| [4] |
GUO Junchi, ZHANG Mingyan, QIN Guangning, XU Qiang, LU Meijuan.
Preliminary Application of the Novel Biomarker TANS01 in Cardiovascular Risk Assessment among Individuals with Phlegm-dampness Constitution
[J]. Chinese General Practice, 2026, 29(27): 3924-3930.
|
| [5] |
WANG Wei, YU Fei, YAN Xiaohong.
Application and Mechanisms of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure with Different Etiologies: Evidence from Ischemic and Non-ischemic Heart Failure
[J]. Chinese General Practice, 2026, 29(27): 3976-3984.
|
| [6] |
ZHAO Yiru, HAO Xinyu, ZHAO Lei, ZHANG Caihui, WANG Zhaoxia, ZHANG Yueying.
Summary of the Best Evidence for the Management of Diuretic Resistance in Patients with Heart Failure
[J]. Chinese General Practice, 2026, 29(25): 3694-3703.
|
| [7] |
YANG Wenjuan, XIN Chuanwei, ZHANG Meiling.
Interpretation of the Update to the 2024 Version of the Criteria for Potentially Inappropriate Medication in Chinese Elderly (PIM-China)
[J]. Chinese General Practice, 2026, 29(24): 3409-3415.
|
| [8] |
LI Xueni, LIU Gejing, LIU Yongming.
Efficacy and Safety of Semaglutide in Patients with Heart Failure: a Meta-Analysis
[J]. Chinese General Practice, 2026, 29(24): 3509-3519.
|
| [9] |
XIE Wan, TU Xulian, WU Liping, LIU Xia, LI Xiaoyan, LENG Mingyue, YANG Xueqing, LI Li.
A Systematic Review of Guidelines and Expert Consensus Related to Pain Management in Endometriosis
[J]. Chinese General Practice, 2026, 29(23): 3351-3358.
|
| [10] |
DUAN Yi, YANG Qingcheng, SHI Yuanlong, HE Liangliang, FAN Daoguang, GAO Yonglong, DUAN Lincan, CHEN Nan.
Clinical Research Progress on Programmed Death 1/Programmed Death-ligand 1 Inhibitors Combined with Novel Therapies in Advanced Non-small Cell Lung Cancer
[J]. Chinese General Practice, 2026, 29(23): 3385-3392.
|
| [11] |
ZHANG Xinwen, WEI Guangcheng, ZHANG Xieyu, SHI Jinjie, LI Xiaoxu, MA Rui, YA Yulong, PENG Jiucheng, CAO Wei.
The Causal Relationship between Sleep Patterns and Serum Uric Acid: a Bidirectional Mendelian Randomization Study
[J]. Chinese General Practice, 2026, 29(17): 2354-2360.
|
| [12] |
LI Shilong, WANG He, ZHOU Xiaoyu, FU Lei, ZHAO Zhuo, HUA Chengjun, SI Chunying.
Advances in the Study of Cardiac Macrophages in Heart Failure with Preserved Ejection Fraction
[J]. Chinese General Practice, 2026, 29(15): 2084-2091.
|
| [13] |
ZOU Jian, LI Wanping, GE Handa, JIN Zhe, RUFEINA· Tuerxun, LI Juan, WEI Anhua, FENG Da.
Study on Potentially Inappropriate Medication Use among the Community Elderly Patients in Hubei Province
[J]. Chinese General Practice, 2026, 29(13): 1759-1765.
|
| [14] |
YANG Lei, GUAN Hua.
Application Progress of Generative Artificial Intelligence in Weight Management
[J]. Chinese General Practice, 2026, 29(12): 1533-1540.
|
| [15] |
LIN Xiaojie, YANG Ying, WANG Haoxiang.
Research Progress on the Evaluation Indicator System for Primary Healthcare Services and Management
[J]. Chinese General Practice, 2026, 29(10): 1256-1266.
|